ACTIVE

Pfizer

Export PDF

Financial year 2025 · closed on 30/11/2025

Net result

3,7 M €

-84.2% YoY

Revenue

358,3 M €

+6.5% YoY

Equity

130,2 M €

+2.9% YoY

Workforce

297,0 ETP

-8.0% YoY

What does Pfizer do?

Pfizer is a Public limited company incorporated in 1954. Its registered office is in Ixelles. It employs on average 297,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0401.994.823

Incorporation

01/02/1954

Legal form

Public limited company

Registered office

Boulevard de la Plaine 17
1050 Ixelles · BruxellesSee on map

Contributed capital

40 805 900,00 €

Latest accounts

30/11/2025

Average workforce

297,0 ETP

Joint committees (3)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2014		2013		2012		2011		2009		2008		2007		2006
Income statement
Revenue	358,3 M €	+6.5%	336,5 M €	-3.7%	349,4 M €	-36.3%	548,2 M €	+16.8%	469,5 M €	+95.5%	240,2 M €	+8.9%	220,6 M €	+48.4%	148,7 M €	+17.2%	126,8 M €	-58.2%	303,7 M €	-5.2%	320,4 M €	-18.1%	391,1 M €	-15.3%	461,6 M €	+28.9%	358 M €	+2.2%	350,4 M €	+2.9%	340,5 M €	+9.4%	311,2 M €
EBITDA	30,2 M €	-26.0%	40,8 M €	+132%	17,5 M €	-54.4%	38,5 M €	+39.2%	27,6 M €	+43.2%	19,3 M €	+24.7%	15,5 M €	-0.7%	15,6 M €	+42.6%	10,9 M €	-60.5%	27,6 M €	+365%	5,9 M €	-84.6%	38,6 M €	+213%	-34,3 M €	-206%	-11,2 M €	-187%	12,8 M €	+306%	-6,2 M €	-5.9%	-5,9 M €
Operating result	15,1 M €	-58.2%	36,2 M €	+75.2%	20,7 M €	-30.7%	29,8 M €	+10.1%	27,1 M €	+83.9%	14,7 M €	+18.3%	12,5 M €	+3.1%	12,1 M €	-10.3%	13,5 M €	-47.1%	25,5 M €	+286%	6,6 M €	-82.0%	36,7 M €	+208%	-34 M €	-217%	-10,7 M €	-154%	19,8 M €	+236%	-14,5 M €	-223%	-4,5 M €
Net result	3,7 M €	-84.2%	23,2 M €	+79.7%	12,9 M €	-40.3%	21,6 M €	+10.7%	19,5 M €	+102%	9,7 M €	+2.9%	9,4 M €	+16.7%	8 M €	-33.9%	12,2 M €	-38.1%	19,6 M €	+11851%	-167 k €	-100%	43,2 M €	-87.5%	345,8 M €	+117%	159,7 M €	+973%	14,9 M €	+180%	-18,6 M €	-163%	-7,1 M €
Balance sheet
Equity	130,2 M €	+2.9%	126,5 M €	+22.4%	103,3 M €	+14.3%	90,4 M €	-23.9%	118,8 M €	+19.7%	99,3 M €	-28.9%	139,7 M €	+55.6%	89,8 M €	+9.8%	81,7 M €	-47.5%	155,7 M €	+14.4%	136,1 M €	-77.4%	601,5 M €	+7.7%	558,3 M €	+175%	202,9 M €	-2.5%	208,2 M €	+7.7%	193,3 M €	-8.8%	211,9 M €
Total assets	377,4 M €	-20.5%	474,6 M €	+23.8%	383,4 M €	+34.4%	285,3 M €	+12.0%	254,7 M €	+31.2%	194,2 M €	-31.6%	283,8 M €	+70.0%	166,9 M €	+26.7%	131,8 M €	-46.1%	244,5 M €	-4.4%	255,9 M €	-63.9%	708 M €	-2.4%	725,1 M €	+85.9%	390 M €	-0.6%	392,3 M €	-3.2%	405,5 M €	+9.0%	371,9 M €
Cash	23,9 M €	+12.1%	21,3 M €	-2.7%	21,9 M €	+2925%	724,7 k €	-98.2%	40,7 M €	+362%	8,8 M €	-90.3%	90,5 M €	+326%	21,2 M €	+846%	2,2 M €	-98.0%	110,9 M €	-8.5%	121,2 M €	-77.1%	530,5 M €	+13.5%	467,2 M €	+3915%	11,6 M €	+4.1%	11,2 M €	-44.6%	20,2 M €	+1289%	1,5 M €
Debts	224,7 M €	-33.6%	338,4 M €	+35.8%	249,2 M €	+36.4%	182,6 M €	+40.3%	130,1 M €	+45.8%	89,2 M €	-34.0%	135,2 M €	+92.3%	70,3 M €	+55.3%	45,3 M €	-39.8%	75,3 M €	-17.9%	91,7 M €	+50.8%	60,8 M €	-45.1%	110,7 M €	-29.6%	157,3 M €	-11.1%	177 M €	-15.0%	208,1 M €	+33.8%	155,5 M €
Other
Workforce	297,0 ETP	-8.0%	323,0 ETP	-4.5%	338,2 ETP	+0.6%	336,3 ETP	+0.9%	333,4 ETP	+1.0%	330,1 ETP	+3.4%	319,4 ETP	+14.2%	279,6 ETP	+3.4%	270,3 ETP	-2.9%	278,5 ETP	-9.4%	307,5 ETP	-21.6%	392,1 ETP	-8.5%	428,6 ETP	+12.9%	379,5 ETP	-7.9%	412,0 ETP	-5.0%	433,8 ETP	-12.7%	497,1 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€

See the valuation

Governance

Board of directors

Seen on filing of 30/11/2014 · 3 active · 16 ended

Active mandates

Laurence Einsweiler

Director · since 01 septembre 2013 · until 15 mai 2019

Active

Didier Vinel

Director · since 01 avril 2012 · until 20 mai 2015

Active

Karel Van De Sompel

Managing director · since 01 mars 2012 · until 20 mai 2015

Active

Ended mandates

Karel Van De Sompel

Director · since 01 mars 2012 · until 20 mai 2015

Ended

Erik Brouwer

Director · since 27 septembre 2011 · until 01 septembre 2013

Ended

Erik Brouwer

Director · since 27 septembre 2011 · until 17 mai 2017

Ended

Etienne CATTHOOR

Director · since 27 mai 2009 · until 01 mars 2012

Ended

At this address

Other companies at this address

Company	CBE no.
HOSPIRA BENELUX● Active	0449.591.040
PFIZER EUROPE MA EEIG● Active	0696.658.156
WYETH LEDERLE VACCINES● Active	0460.950.631

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/12/2024	01/12/2023	01/12/2022	01/12/2021	01/12/2020	01/12/2019
Closing of the financial year	30/11/2025	30/11/2024	30/11/2023	30/11/2022	30/11/2021	30/11/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	02/06/2026	23/05/2025	21/05/2024	23/05/2023	01/06/2022	31/05/2021
General meeting	29/05/2026	21/05/2025	15/05/2024	17/05/2023	18/05/2022	19/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	30/11/2025	29/05/2026	02/06/2026	French	PDF
Full model	30/11/2024	21/05/2025	23/05/2025	French	PDF
Full model	30/11/2023	15/05/2024	21/05/2024	French	PDF
Full model	30/11/2022	17/05/2023	23/05/2023	French	PDF
Full model	30/11/2021	18/05/2022	01/06/2022	French	PDF
Full model	30/11/2020	19/05/2021	31/05/2021	French	PDF
Full model	30/11/2019	20/05/2020	29/06/2020	French	PDF
Full model	30/11/2018	15/05/2019	22/05/2019	French	PDF
Full model	30/11/2017	16/05/2018	30/05/2018	French	PDF
Full model	30/11/2016	17/05/2017	09/06/2017	French	PDF
Full model	30/11/2015	18/05/2016	15/06/2016	French	PDF
Full model	30/11/2014	20/05/2015	22/06/2015	French	PDF
Full model	30/11/2013	21/05/2014	26/06/2014	French	PDF
Full modelCorrection	30/11/2012	15/05/2013	07/08/2013	French	PDF
Full model	30/11/2012	15/05/2013	27/06/2013	French	PDF
Full model	30/11/2011	16/05/2012	06/06/2012	French	PDF
Full model	30/11/2010	23/05/2011	24/06/2011	French	PDF
Full model	30/11/2009	19/05/2010	03/06/2010	French	PDF
Full model	30/11/2008	27/05/2009	10/07/2009	French	PDF
Full model	30/11/2007	21/05/2008	06/06/2008	French	PDF
Full model	30/11/2006	16/05/2007	24/05/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/11/2014 · 3 active · 16 ended

Active mandates

Laurence Einsweiler

Director · since 01 septembre 2013 · until 15 mai 2019

Active

Didier Vinel

Director · since 01 avril 2012 · until 20 mai 2015

Active

Karel Van De Sompel

Managing director · since 01 mars 2012 · until 20 mai 2015

Active

Ended mandates

Karel Van De Sompel

Director · since 01 mars 2012 · until 20 mai 2015

Ended

Erik Brouwer

Director · since 27 septembre 2011 · until 01 septembre 2013

Ended

Erik Brouwer

Director · since 27 septembre 2011 · until 17 mai 2017

Ended

Etienne CATTHOOR

Director · since 27 mai 2009 · until 01 mars 2012

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates02/04/2026
DEMISSIONS, NOMINATIONS
PDF
Mandates19/01/2026
DEMISSIONS, NOMINATIONS
PDF
Mandates26/06/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates21/03/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates24/05/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates06/12/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates19/08/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates26/08/2021
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

01/12/2025
nominationRéginald Decraene — administrateur
2025
Annual accounts 20253,7 M €↓
01/09/2025
nominationAnne De Backer — Director People Experience Belux
21/05/2025
reconductionLaurence Einsweiler — administrateur
21/05/2025
reconductionKPMG Réviseurs d'Entreprises SRL — commissaire
01/02/2025
nominationDavid Lepoittevin — administrateur
2024
Annual accounts 202423,2 M €↑
24/04/2024
nominationSteven Veyt — représentant permanent du commissaire
2023
Annual accounts 202312,9 M €↓
27/04/2023
nominationVéronique Gobiet — Category Lead Hospitals
27/04/2023
nominationMicheline Vrancken — Category Lead Rare Diseases
27/04/2023
nominationNathalie Gonnissen — Category Lead Customer Experience Management
27/04/2023
nominationCatherine Pélissier — Category Lead Belux Oncology
27/04/2023
nominationAna Moreno Morales de Setien — Category Lead Primary Care
27/04/2023
nominationDimitri Galle — Category Lead Inflammation & Immunology Belux
27/04/2023
nominationMachiel De Dauw — Tender and Contracting Manager
27/04/2023
nominationKathleen Van der Slach — Institution Commercial Office Operations Development
2022
Annual accounts 202221,6 M €↑
01/09/2022
nominationAn Van Gerven — administrateur
10/06/2022
reconductionKPMG Réviseurs d'Entreprises SRL — commissaire
2021
Annual accounts 202119,5 M €↑
2020
Annual accounts 20209,7 M €↑
2019
Annual accounts 20199,4 M €↑
2018
Annual accounts 20188 M €↓
2017
Annual accounts 201712,2 M €↓
2014
Annual accounts 201419,6 M €↑
2013
Annual accounts 2013-167 k €↓
2012
Annual accounts 201243,2 M €↓
2011
Annual accounts 2011345,8 M €↑
01/06/2010
revocationAnne De Backer — MR MOS Lead
2009
Annual accounts 2009159,7 M €↑
2008
Annual accounts 200814,9 M €↑
2007
Annual accounts 2007-18,6 M €↓
2006
Annual accounts 2006-7,1 M €
01/02/1954
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Pfizer

Overview

What does Pfizer do?

Trend over 17 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline